BioCentury
ARTICLE | Clinical News

Lucentis ranibizumab regulatory update

March 3, 2014 8:00 AM UTC

Novartis said Japan approved Lucentis ranibizumab to treat diabetic macular edema (DME). Lucentis is approved in Japan to treat wet age-related macular degeneration (AMD), visual impairment due to mac...